GlassScriptPhysician profile
Thomas Sanderson Gavigan
NPI 1407267545
$11,816.11
in general payments reported to CMS, 2019-2025
9 companies · $1,436 in 2025
The $1,436 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,234 · 2020: $115 · 2021: $1,325 · 2022: $2,306 · 2023: $1,678 · 2024: $1,721 · 2025: $1,436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,056 · Education: $1,500 · Travel and Lodging: $1,265 · Gift: $14.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,056.16 |
| Education | $1,500.00 |
| Travel and Lodging | $1,264.90 |
| Gift | $14.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,848.62 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Allergan, INC. | $1,102.09 | 2019 | |
| Stryker Corporation | $307.34 | 2023 | Spy-Phi System |
| Zimmer Biomet Holdings, INC. | $186.14 | 2021 | |
| Innocoll Pharmaceuticals Limited | $124.46 | 2022 | |
| Conmed Corporation | $110.36 | 2021 | |
| Covidien LP | $100.75 | 2020 | |
| Enterra Medical, INC. | $22.38 | 2023 | |
| Endo Pharmaceuticals INC. | $13.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Gavigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.